{
  "main_header": {
    "sid": 1003715,
    "name": "Trident Lifeline",
    "stock_name": "Trident Lifeline",
    "full_name": "Trident Lifeline Ltd",
    "name_url": "stocks-analysis/trident-lifeline",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "298.95",
    "chg": 8.9,
    "chgp": "3.07%",
    "dir": 1,
    "prev_price": "290.05",
    "mcapval": "342.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543616,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0MKA01014",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": 49200,
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trident-lifeline-1003715-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Trident Lifeline falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-trident-lifeline-fallingrising-3763212",
        "imagepath": "",
        "date": "2025-12-19 02:07:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Pressure Evident</strong></p>\n<p>Trident Lifeline’s shares have been under pressure over the past week, registering a decline of 3.97%, significantly underperforming the Sensex’s modest 0.40% drop during the same period. This downward trend has extended over the last two consecutive trading days, signalling a short-term correction or profit-taking phase among investors. The one-month performance further emphasises this weakness, with the stock falling 7.69%, while the Sensex remained relatively stable, down just 0.23%.</p>\n<p>Despite this recent softness, the stock has managed to deliver a positive year-to-date return of 2.89%, though this lags behind the Sensex’s 8.12% gain. Over a one-year horizon, the stock’s 2.89% appreciation also trails the benchmark’s 5.36% rise. Howe..."
      },
      {
        "title": "Trident Lifeline Sees Revision in Market Evaluation Amid Strong Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-upgraded-to-buy-by-marketsmojo-on-strong-financial-and-quality-metrics-3741253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TridentLifeline_mojoScore_3741253.png",
        "date": "2025-12-02 10:09:20",
        "description": "Trident Lifeline, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation metrics. This shift reflects a reassessment of the company’s financial health, valuation, technical outlook, and overall quality, signalling renewed investor interest and a changing market perspective."
      },
      {
        "title": "Trident Lifeline Reports Strong Financial Performance Amid Mixed Stock Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifelines-financial-trend-improves-from-flat-to-very-positive-with-record-sales-3697624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TridentLifeline_fintrenddot_3697624.png",
        "date": "2025-11-13 12:02:48",
        "description": "Trident Lifeline, a microcap in the Pharmaceuticals & Biotechnology sector, reported strong financial results for the quarter ending September 2025, with record net sales and profit figures. Despite recent stock challenges, the company has shown significant long-term growth, outperforming the Sensex over a three-year period."
      },
      {
        "title": "How has been the historical performance of Trident Lifeline?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-trident-lifeline-3695730",
        "imagepath": "",
        "date": "2025-11-13 00:37:15",
        "description": "Answer:\nThe historical performance of Trident Lifeline shows significant growth in various financial metrics over the past four years.\n\nBreakdown:\nTrident Lifeline's net sales have increased from 21.77 Cr in Mar'22 to 86.96 Cr in Mar'25, reflecting a strong upward trend. Total operating income has followed a similar trajectory, rising from 21.77 Cr to 86.96 Cr during the same period. The company's total expenditure, excluding depreciation, has also grown, from 19.06 Cr in Mar'22 to 72.11 Cr in Mar'25. Operating profit (PBDIT) has improved markedly, from 3.31 Cr in Mar'22 to 23.08 Cr in Mar'25, although the operating profit margin has slightly decreased from 12.45% to 17.08%. Profit before tax has risen from 2.98 Cr to 13.61 Cr, leading to a profit after tax increase from 3.95 Cr to 10.49 Cr. The consolidated net profit has also shown growth, moving from 3.95 Cr in Mar'22 to 11.75 Cr in Mar'25. On the balanc..."
      },
      {
        "title": "How has been the historical performance of Trident Lifeline?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-trident-lifeline-3694967",
        "imagepath": "",
        "date": "2025-11-13 00:02:11",
        "description": "Answer:\nThe historical performance of Trident Lifeline shows significant growth in various financial metrics over the past four years.\n\nBreakdown:\nTrident Lifeline's net sales have increased dramatically from 21.77 Cr in Mar'22 to 86.96 Cr in Mar'25, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 21.77 Cr to 86.96 Cr during the same period. The company's total expenditure also grew, from 19.06 Cr in Mar'22 to 72.11 Cr in Mar'25, driven by higher raw material costs and employee expenses. Operating profit (PBDIT) saw a substantial increase, reaching 23.08 Cr in Mar'25, up from just 3.31 Cr in Mar'22. Profit before tax rose from 2.98 Cr in Mar'22 to 13.61 Cr in Mar'25, while profit after tax increased from 3.95 Cr to 10.49 Cr in the same timeframe. The earnings per share (EPS) improved significantly from 4.94 in Mar'22 to 10.22 in Mar'25. On the balance shee..."
      },
      {
        "title": "Why is Trident Lifeline falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-trident-lifeline-fallingrising-3691413",
        "imagepath": "",
        "date": "2025-11-12 00:04:00",
        "description": "As of 11-Nov, Trident Lifeline Ltd's stock price is rising, currently at Rs 318.00, reflecting an increase of Rs 17.25 or 5.74%. The stock has shown strong performance today, outperforming its sector by 5.87% and is close to its 52-week high, just 2.19% away from Rs 324.95. Despite a recent trend reversal after two days of consecutive declines, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the company has demonstrated healthy long-term growth, with net sales increasing at an annual rate of 58.70% and operating profit at 55.07%. Institutional investors have also increased their stake by 0.52% in the last quarter, indicating growing confidence in the company's fundamentals.\n\nIn the broader market context, Trident Lifeline's short-term return over the past week is +6.00%, significantly outperforming the Sensex, which has only gained +0.49% during the ..."
      },
      {
        "title": "When is the next results date for Trident Lifeline?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-trident-lifeline-3677513",
        "imagepath": "",
        "date": "2025-11-06 23:16:33",
        "description": "The next results date for Trident Lifeline is scheduled for 11 November 2025...."
      },
      {
        "title": "Why is Trident Lifeline falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-trident-lifeline-fallingrising-3668487",
        "imagepath": "",
        "date": "2025-11-03 23:39:58",
        "description": "As of 03-Nov, Trident Lifeline Ltd's stock price is currently at Rs 296.50, reflecting a decline of Rs 3.5 or 1.17%. The stock has been underperforming, having lost 5.24% over the last two days and showing a performance today that is 2.47% below its sector. In the past week, the stock has decreased by 0.50%, while its one-month performance matches this decline. Despite a year-to-date increase of 5.89%, the stock has underperformed over the past year, with a decline of 4.57%. Although the stock is trading above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day averages, indicating mixed signals. Additionally, there has been a decrease in investor participation, with delivery volume falling by 3.85% against the 5-day average, which may contribute to the stock's downward pressure.\n\nIn the broader market context, Trident Lifeline's recent performance contrasts with the Sensex, w..."
      },
      {
        "title": "Is Trident Lifeline overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-trident-lifeline-overvalued-or-undervalued-3660304",
        "imagepath": "",
        "date": "2025-10-31 08:10:44",
        "description": "As of 30 October 2025, Trident Lifeline's valuation grade has moved from expensive to very expensive, indicating a significant shift in its perceived market value. The company is currently overvalued, with a PE ratio of 23.10, an EV to EBIT ratio of 24.99, and a Price to Book Value of 5.98. These figures suggest that the stock is trading at a premium compared to its earnings and book value.\n\nIn comparison to its peers, Trident Lifeline's valuation stands out, particularly against Sun Pharma Industries, which has a PE ratio of 35.63, and Cipla, which is valued attractively at a PE of 22.87. The PEG ratio of 0.28 for Trident Lifeline further emphasizes its overvaluation, especially when compared to Divi's Lab's PEG of 2.03. Notably, Trident Lifeline has outperformed the Sensex over various periods, including a 13.93% return year-to-date, which may reflect investor optimism despite the high valuation metrics...."
      }
    ],
    "total": 118,
    "sid": "1003715",
    "stock_news_url": "https://www.marketsmojo.com/news/trident-lifeline-1003715"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "19-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Maniyal H Desai & PACs",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "19-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust & PACs",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On December 16 2025 In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "16-Dec-2025",
      "details": "Allotment of 100200 Equity Shares of Rs. 10/- each upon conversion/ exchange of equal number of warrants",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Trident Lifeline falling/rising?

2025-12-19 02:07:18

Short-Term Price Pressure Evident

Trident Lifeline’s shares have been under pressure over the past week, registering a decline of 3.97%, significantly underperforming the Sensex’s modest 0.40% drop during the same period. This downward trend has extended over the last two consecutive trading days, signalling a short-term correction or profit-taking phase among investors. The one-month performance further emphasises this weakness, with the stock falling 7.69%, while the Sensex remained relatively stable, down just 0.23%.

Despite this recent softness, the stock has managed to deliver a positive year-to-date return of 2.89%, though this lags behind the Sensex’s 8.12% gain. Over a one-year horizon, the stock’s 2.89% appreciation also trails the benchmark’s 5.36% rise. Howe...

Read More

Trident Lifeline Sees Revision in Market Evaluation Amid Strong Financial Trends

2025-12-02 10:09:20

Trident Lifeline, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation metrics. This shift reflects a reassessment of the company’s financial health, valuation, technical outlook, and overall quality, signalling renewed investor interest and a changing market perspective.

Read More

Trident Lifeline Reports Strong Financial Performance Amid Mixed Stock Market Trends

2025-11-13 12:02:48

Trident Lifeline, a microcap in the Pharmaceuticals & Biotechnology sector, reported strong financial results for the quarter ending September 2025, with record net sales and profit figures. Despite recent stock challenges, the company has shown significant long-term growth, outperforming the Sensex over a three-year period.

Read More

How has been the historical performance of Trident Lifeline?

2025-11-13 00:37:15

Answer: The historical performance of Trident Lifeline shows significant growth in various financial metrics over the past four years. Breakdown: Trident Lifeline's net sales have increased from 21.77 Cr in Mar'22 to 86.96 Cr in Mar'25, reflecting a strong upward trend. Total operating income has followed a similar trajectory, rising from 21.77 Cr to 86.96 Cr during the same period. The company's total expenditure, excluding depreciation, has also grown, from 19.06 Cr in Mar'22 to 72.11 Cr in Mar'25. Operating profit (PBDIT) has improved markedly, from 3.31 Cr in Mar'22 to 23.08 Cr in Mar'25, although the operating profit margin has slightly decreased from 12.45% to 17.08%. Profit before tax has risen from 2.98 Cr to 13.61 Cr, leading to a profit after tax increase from 3.95 Cr to 10.49 Cr. The consolidated net profit has also shown growth, moving from 3.95 Cr in Mar'22 to 11.75 Cr in Mar'25. On the balanc...

Read More

How has been the historical performance of Trident Lifeline?

2025-11-13 00:02:11

Answer: The historical performance of Trident Lifeline shows significant growth in various financial metrics over the past four years. Breakdown: Trident Lifeline's net sales have increased dramatically from 21.77 Cr in Mar'22 to 86.96 Cr in Mar'25, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 21.77 Cr to 86.96 Cr during the same period. The company's total expenditure also grew, from 19.06 Cr in Mar'22 to 72.11 Cr in Mar'25, driven by higher raw material costs and employee expenses. Operating profit (PBDIT) saw a substantial increase, reaching 23.08 Cr in Mar'25, up from just 3.31 Cr in Mar'22. Profit before tax rose from 2.98 Cr in Mar'22 to 13.61 Cr in Mar'25, while profit after tax increased from 3.95 Cr to 10.49 Cr in the same timeframe. The earnings per share (EPS) improved significantly from 4.94 in Mar'22 to 10.22 in Mar'25. On the balance shee...

Read More

Why is Trident Lifeline falling/rising?

2025-11-12 00:04:00

As of 11-Nov, Trident Lifeline Ltd's stock price is rising, currently at Rs 318.00, reflecting an increase of Rs 17.25 or 5.74%. The stock has shown strong performance today, outperforming its sector by 5.87% and is close to its 52-week high, just 2.19% away from Rs 324.95. Despite a recent trend reversal after two days of consecutive declines, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the company has demonstrated healthy long-term growth, with net sales increasing at an annual rate of 58.70% and operating profit at 55.07%. Institutional investors have also increased their stake by 0.52% in the last quarter, indicating growing confidence in the company's fundamentals. In the broader market context, Trident Lifeline's short-term return over the past week is +6.00%, significantly outperforming the Sensex, which has only gained +0.49% during the ...

Read More

When is the next results date for Trident Lifeline?

2025-11-06 23:16:33

The next results date for Trident Lifeline is scheduled for 11 November 2025....

Read More

Why is Trident Lifeline falling/rising?

2025-11-03 23:39:58

As of 03-Nov, Trident Lifeline Ltd's stock price is currently at Rs 296.50, reflecting a decline of Rs 3.5 or 1.17%. The stock has been underperforming, having lost 5.24% over the last two days and showing a performance today that is 2.47% below its sector. In the past week, the stock has decreased by 0.50%, while its one-month performance matches this decline. Despite a year-to-date increase of 5.89%, the stock has underperformed over the past year, with a decline of 4.57%. Although the stock is trading above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day averages, indicating mixed signals. Additionally, there has been a decrease in investor participation, with delivery volume falling by 3.85% against the 5-day average, which may contribute to the stock's downward pressure. In the broader market context, Trident Lifeline's recent performance contrasts with the Sensex, w...

Read More

Is Trident Lifeline overvalued or undervalued?

2025-10-31 08:10:44

As of 30 October 2025, Trident Lifeline's valuation grade has moved from expensive to very expensive, indicating a significant shift in its perceived market value. The company is currently overvalued, with a PE ratio of 23.10, an EV to EBIT ratio of 24.99, and a Price to Book Value of 5.98. These figures suggest that the stock is trading at a premium compared to its earnings and book value. In comparison to its peers, Trident Lifeline's valuation stands out, particularly against Sun Pharma Industries, which has a PE ratio of 35.63, and Cipla, which is valued attractively at a PE of 22.87. The PEG ratio of 0.28 for Trident Lifeline further emphasizes its overvaluation, especially when compared to Divi's Lab's PEG of 2.03. Notably, Trident Lifeline has outperformed the Sensex over various periods, including a 13.93% return year-to-date, which may reflect investor optimism despite the high valuation metrics....

Read More

View All News